CONFERENCE COMMITTEE REP. NO. 119

 

Honolulu, Hawaii

                 , 2023

 

RE:    H.B. No. 1113

       H.D. 1

       S.D. 1

       C.D. 1

 

 

 

Honorable Scott K. Saiki

Speaker, House of Representatives

Thirty-Second State Legislature

Regular Session of 2023

State of Hawaii

 

Honorable Ronald D. Kouchi

President of the Senate

Thirty-Second State Legislature

Regular Session of 2023

State of Hawaii

 

Sirs:

 

     Your Committee on Conference on the disagreeing vote of the House of Representatives to the amendments proposed by the Senate in H.B. No. 1113, H.D. 1, S.D. 1, entitled:

 

"A BILL FOR AN ACT RELATING TO THE DRUG AND ALCOHOL TOXICOLOGY TESTING LABORATORY,"

 

having met, and after full and free discussion, has agreed to recommend and does recommend to the respective Houses the final passage of this bill in an amended form.

 

     The purpose of this measure is to:

 

     (1)  Allow monies in the State Highway Fund to be expended for the cost of maintaining a Drug and Alcohol Toxicology Testing Laboratory;

 

     (2)  Require monies in the Drug and Alcohol Toxicology Testing Laboratory Special Fund to be administered and expended by the Department of Transportation or appropriated as a grant-in-aid to the emergency services department of a county with a population of five hundred thousand or more to support a Drug and Alcohol Toxicology Testing Laboratory;

 

     (3)  Change the name of the State Drug and Alcohol Toxicology Testing Laboratory, and its special fund, to repeal reference to the "State" to reflect its expanded scope;

 

     (4)  Appropriate funds from the State Highway Fund to the Drug and Alcohol Toxicology Testing Laboratory Special Fund;

 

     (5)  Appropriate funds out of the Drug and Alcohol Toxicology Testing Laboratory Special Fund for the establishment and maintenance of a Drug and Alcohol Toxicology Testing Laboratory; and

 

     (6)  Require reports to the Legislature on expenditures made from the Drug and Alcohol Toxicology Testing Laboratory Special Fund.

 

     Your Committee on Conference has amended this measure by:

 

     (1)  Appropriating $2,000,000 for fiscal year 2023-2024 and $400,000 for fiscal year 2024-2025 for the establishment and maintenance of a Drug and Alcohol Toxicology Testing Laboratory, including the costs of laboratory instrumentation, facility renovation and security upgrades, office furniture and supplies, laboratory equipment, and other purposes that support a Drug and Alcohol Toxicology Testing Laboratory;

 

     (2)  Changing the effective date to July 1, 2023; and

 

     (3)  Making technical, nonsubstantive amendments for the purposes of clarity, consistency, and style.

 

     As affirmed by the record of votes of the managers of your Committee on Conference that is attached to this report, your Committee on Conference is in accord with the intent and purpose of H.B. No. 1113, H.D. 1, S.D. 1, as amended herein, and recommends that it pass Final Reading in the form attached hereto as H.B. No. 1113, H.D. 1, S.D. 1, C.D. 1.

 


 

Respectfully submitted on behalf of the managers:

 

ON THE PART OF THE SENATE

 

ON THE PART OF THE HOUSE

 

____________________________

CHRIS LEE

Chair

 

____________________________

DAVID A. TARNAS

Co-Chair

____________________________

DRU KANUHA

Co-Chair

 

____________________________

SCOTT Y. NISHIMOTO

Co-Chair